rilmazafone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
alozafone derivatives 2380 99593-25-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • 450191-S
  • rilmazafone
  • rilmazafone hydrochloride
  • rilmazafone hydrochloride hydrate
  • rhythmy
  • rilmazafone HCl
  • Molecular weight: 475.33
  • Formula: C21H20Cl2N6O3
  • CLOGP: 0.57
  • LIPINSKI: 0
  • HAC: 9
  • HDO: 2
  • TPSA: 123.21
  • ALOGS: -4.78
  • ROTB: 7

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hepatic function abnormal 31.53 30.25 14 608 73093 79670673

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D006993 Hypnotics and Sedatives

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Insomnia indication 193462001




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.71 acidic
pKa2 8.05 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01564 KEGG_DRUG
C0073378 UMLSCUI
CHEBI:135767 CHEBI
CHEMBL2107197 ChEMBL_ID
C041075 MESH_SUPPLEMENTAL_RECORD_UI
5933 INN_ID
85815-37-8 SECONDARY_CAS_RN
CU3H37T766 UNII
5069 PUBCHEM_CID

Pharmaceutical products:

None